Looks like next quarter will look stronger than latest quarter. Nipent sell, J&J royality and first royalty on Dacogen. Here's what I see 14M +5M and first Dacogen royality (7.2M @ 20%)=1.44M. Total around 20M. This should boast SUPG cash position around 10M+...last quarter was around 20M, however they had to payout 9M (Montigen deal) and 2.1M to get rights back on Nipent. Dacogen sales will be higher than 25M estimate. See it closer to 40M. Today U.S. gave Dacogen fast track status for AML. I believe the pieces are falling into place for Dacogen to reach the 500M worldwide sales.